(Q44553347)

English

Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Eamonn Shanahan

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

John P Kelly

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Thomas J Connor

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

European Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1021-1027

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

The content of ecstasy tablets: implications for the study of their long-term effects.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Forced swim test-induced neurochemical endocrine, and immune changes in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Assessing antidepressant activity in rodents: recent developments and future needs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Selective serotonin-reuptake inhibitors: an update

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Relation between brain 5-HIAA levels and the release of serotonin into brain synapses

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02802.X

21 January 2018

Identifiers

10.1046/J.1460-9568.2003.02802.X

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44553347&oldid=2027707943"